Who owns PHIO PHARMACEUTICALS CORP?
- Ticker: PHIO
- CUSIP Number: 71880w501
Tip: Access positions for across all investors
Analyze quarterly positions in Phio Pharmaceuticals Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Phio Pharmaceuticals Corp stock
Who bought or sold PHIO PHARMACEUTICALS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 88k | $217k | 80% | Sep 2025 |
|
| Geode Capital Management | 58k | $144k | 0% | Sep 2025 |
|
| Cetera Investment Advisers | 34k | $83k | 3% | Sep 2025 |
|
| Morgan Stanley | 6.0k | $14k | 100% | Jun 2025 |
|
| SBI Securities | 1.1k | $2.7k | -42% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 413.00 | $1.0k | 100% | Sep 2025 |
|
| Tower Research Capital | 406.00 | $1.0k | 100% | Sep 2025 |
|
| Assetmark | 110.00 | $272.998000 | 0% | Sep 2025 |
|
| UBS Group | 13.00 | $31.999500 | 100% | Sep 2025 |
|
| Activest Wealth Management | 9.00 | $21.999600 | 0% | Sep 2025 |
|
Who sold out of Phio Pharmaceuticals Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2025 | 14k | $34k |
| Royal Bank of Canada | Jun 2025 | 3.5k | $8.0k |
| Mount Yale Investment Advisors | Jun 2025 | 27.00 | $62.999100 |